Xenon Pharmaceuticals posts first-quarter loss of $3.3 million
BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $3.3 million in its first quarter.
The Burnaby, British Columbia-based company said it had a loss of 23 cents per share.
The gene therapy biotech company posted revenue of $601,000 in the period.
Xenon Pharmaceuticals shares have declined 17 per cent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.67, a fall of 51 per cent in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at http://www.zacks.com/ap/XENE
_____
Keywords: Xenon Pharmaceuticals, Earnings Report
News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.
Join the Conversation!
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.
